Bio-Path Holdings, Inc.
BPTH· OTC
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001558370-22-017789
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$3.54M | -$2.07M | -$2.97M | -$2.24M |
| EPS Diluted | -$0.49 | -$0.29 | -$0.80 | -$0.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end